The Causal Effect of Gut Microbiota and Plasma Metabolome on Lung Cancer and the Heterogeneity across Subtypes: A Mendelian Randomization Study
Journal of Personalized Medicine · 25.04.2024 · 14 (5) · 453
DOI: 10.3390/jpm14050453 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 25.04.2024. Verfasst von Jun Zeng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha 410008, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Clinical Research Center for Geriatric Disorders, Natural Science Foundation of Hunan Province, National Multidisciplinary Cooperative Diagnosis and Treatment Capacity Building Project for Major Diseases.
Abstract (Originalsprache)
The causal effect and pathways of gut microbiota and plasma metabolome on lung cancer have been important topics for personalized medicine; however, the heterogeneity of lung cancer subtypes has not gained enough attention in previous studies. This study sought to employ a Mendelian randomization analysis to screen the specific gut microbiota and plasma metabolome, which may have a causal effect on lung cancer. We further extended our analysis to estimate the effects of these exposures on various pathological subtypes of lung cancer. Furthermore, a mediation analysis was performed to identify the potential pathway underlying the influence of microbiota and metabolites. Our study identified 13 taxa and 15 metabolites with a causal association with the overall risk of lung cancer. Furthermore, we found 8 taxa and 14 plasma metabolites with a causal effect on lung adenocarcinoma, 4 taxa and 10 metabolites with a causal effect on squamous cell lung carcinoma, and 7 taxa and 16 metabolites with a causal effect on SCLC. We also identified seven mediation pathways that could potentially elucidate the influence of these microbiota and metabolites on overall lung cancer or special subtypes. Our study highlighted the heterogeneity of the gut microbiome and plasma metabolome in a lung cancer subtype and elucidated the potential underlying mechanisms. This could pave the way for more personalized lung cancer prevention and treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha 410008, China.
- Hunan Engineering Research Center for Pulmonary Nodules Precise Diagnosis & Treatment, Changsha 410008, China.
- National Clinical Research Center for Geriatric Disorders, Changsha 410008, China.
- Xiangya Lung Cancer Center, Xiangya Hospital, Central South University, Changsha 410008, China.
- Departments of Clinical Pharmacology and Respiratory Medicine, Hunan Key Laboratory of Pharmacogenetics, and National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsh…
- Institute of Clinical Pharmacology, Engineering Research Center for Applied Technology of Pharmacogenomics of Ministry of Education, Central South University, Changsha 410008, China.
ORCID-Profile: Yang Gao
Förderung
- National Clinical Research Center for Geriatric Disorders
- Natural Science Foundation of Hunan Province
- National Multidisciplinary Cooperative Diagnosis and Treatment Capacity Building Project for Major Diseases
- National Natural Science Foundation of China
Zitieren
APA
Zeng, J., Yi, B., Chang, R., Li, J., Zhu, J., Yu, Z., Li, X., & Gao, Y. (2024). The Causal Effect of Gut Microbiota and Plasma Metabolome on Lung Cancer and the Heterogeneity across Subtypes: A Mendelian Randomization Study. Journal of Personalized Medicine, 14(5), 453. https://doi.org/10.3390/jpm14050453
Vancouver
Zeng J, Yi B, Chang R, Li J, Zhu J, Yu Z, et al. The Causal Effect of Gut Microbiota and Plasma Metabolome on Lung Cancer and the Heterogeneity across Subtypes: A Mendelian Randomization Study. Journal of Personalized Medicine. 2024;14(5):453. doi:10.3390/jpm14050453
BibTeX
@article{Zeng2024,
author = {Zeng, Jun and Yi, Bin and Chang, Ruimin and Li, Jiashuo and Zhu, Jiebo and Yu, Zhongjie and Li, Xi and Gao, Yang},
title = {The Causal Effect of Gut Microbiota and Plasma Metabolome on Lung Cancer and the Heterogeneity across Subtypes: A Mendelian Randomization Study},
journal = {Journal of Personalized Medicine},
year = {2024},
volume = {14},
number = {5},
pages = {453},
doi = {10.3390/jpm14050453}
}
EUVIMED